Open this publication in new window or tab >> Show others...
2021 (English) In: MedrxivArticle in journal (Refereed) Published
Abstract [en] More knowledge regarding persistence of antibody response to SARS-CoV-2 infections in the general population with mild symptoms is needed. We measured and compared levels of SARS CoV-2 spike- and nucleocapsid-specific IgG-antibodies in serum samples from 145 laboratory confirmed COVID-19 cases and 324 non-cases. The IgG-antibody levels against the spike protein in cases were stable over the time-period studied (14 to 256 days), while antibody levels against the nucleocapsid protein decreased over time
National Category
Infectious Medicine
Identifiers urn:nbn:se:ri:diva-56949 (URN) 10.1101/2021.06.16.21258960 (DOI)
Note This project was exclusively funded by the Public Health Agency of Sweden via an assignment (S2020_05026) from the Ministry of Health and Social Affairs, Government of Sweden.
2021-11-192021-11-192025-09-23 Bibliographically approved